# Do Men and Women Get Different GLP-1 Side Effects? | Buy This GLP

What clinical trial reports and a matched tirzepatide study tell us about GLP-1 side effects in men and women.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/do-men-and-women-get-different-glp1-side-effects
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Safety

# Do Men and Women Get Different GLP-1 Side Effects?

A tirzepatide records study found a difference in recorded nausea and vomiting. Clinical trial reports provide examples for other symptoms.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Recorded nausea and vomiting · Adults with obesity and HFpEF taking tirzepatide · Men · 3.8% · Women · 7.9% · Matched health records study. Both groups took tirzepatide.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   One medical records study found fewer recorded nausea and vomiting events in men than in women taking tirzepatide in a group with obesity and a specific type of heart failure.
-   Analyses of clinical trial data also report some side effects by sex. The findings differ by drug, side effect and patient group.

Nausea and vomiting are among the [common side effects of GLP-1 drugs](https://buythisglp.com/research/what-are-the-side-effects-of-a-glp1) reported in clinical trials. To understand whether their frequency differs by sex, it helps to distinguish symptoms collected in clinical trials from diagnoses entered in routine medical records.

## What did the tirzepatide records study find?

Researchers matched 1,654 men with 1,654 women taking tirzepatide. All had obesity and heart failure with preserved ejection fraction (HFpEF). Nausea and vomiting were recorded in 3.8% of men and 7.9% of women, with an estimated hazard ratio of 0.50. For diarrhea the hazard ratio was 0.84 (95% CI 0.59 to 1.19), an inconclusive difference [\[1\]](https://buythisglp.com/research/do-men-and-women-get-different-glp1-side-effects#ref-1).

The study compared people who were already taking tirzepatide. It did not establish how much the drug itself contributes to the difference, and electronic records can miss symptoms that patients or clinicians do not document.

## What did clinical trials report by sex?

A post hoc analysis of the SURPASS type 2 diabetes trials reported gastrointestinal adverse events by sex and other baseline factors. Digestive symptoms occurred in both sex groups. Estimates can vary across trials, doses and comparators. Eli Lilly funded the subgroup analysis [\[2\]](https://buythisglp.com/research/do-men-and-women-get-different-glp1-side-effects#ref-2).

The U.S. Wegovy label provides another example. In three pooled studies, hair loss was reported in 4% of female and 0.9% of male participants receiving 2.4 mg injections, versus 2% and 0% with placebo, respectively [\[3\]](https://buythisglp.com/research/do-men-and-women-get-different-glp1-side-effects#ref-3). The same label reports sex-specific data on [hip and pelvic fractures in the cardiovascular trial](https://buythisglp.com/research/do-glp1-drugs-weaken-your-bones), a different outcome studied in a different patient population. These findings do not give a single prediction for all GLP-1 medicines.

## Frequently asked

Do men get less nausea than women on tirzepatide?

A matched study of adults with obesity and heart failure with preserved ejection fraction recorded nausea and vomiting in 3.8% of men and 7.9% of women taking tirzepatide. The result describes that patient group and does not count symptoms that were never recorded.

Do clinical trials report GLP-1 side effects by sex?

Some trial analyses do. A SURPASS analysis reported digestive adverse events by sex, and the Wegovy label reports sex-specific hair loss rates from pooled injection trials.

## Sources

1.  \[1\] Mortada I, et al. (2026). Sex-based differences in clinical outcomes among patients with obesity and heart failure with preserved ejection fraction treated with tirzepatide Therapeutic Advances in Cardiovascular Disease. [PMID 42605954](https://pmc.ncbi.nlm.nih.gov/articles/PMC13482057/)
2.  \[2\] De Block C, et al. (2025). Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics Diabetes Therapy. [PMID 39531161](https://pmc.ncbi.nlm.nih.gov/articles/PMC11759727/)
3.  \[3\] Novo Nordisk (2026). Wegovy U.S. prescribing information DailyMed. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)

## More in Safety

-   [
    
    Follow the prescription · Storefront → pharmacy → label
    
    ### How to Verify an Online Pharmacy for GLP-1 Medication
    
    ](https://buythisglp.com/research/how-to-verify-online-pharmacy-for-glp1)
-   [
    
    Warm delivery? Pause first. · Save the evidence. Call the pharmacy.
    
    ### Semaglutide Arrived Warm? What to Do Before Using It
    
    ](https://buythisglp.com/research/semaglutide-arrived-warm)
-   [
    
    503A pharmacy · 503B facility · Prescription · per patient · or office stock · CGMP · exempt · required · Oversight · state license · FDA, risk-based · Adverse events · no FDA duty · must report · FDA approval · no · no
    
    ### 503A vs 503B Pharmacy Rules for Compounded GLP-1s
    
    ](https://buythisglp.com/research/503a-vs-503b-pharmacy-compounded-glp1)
